ClinicalTrials.govpublic full text
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
triple negative breast cancer, locally advanced breast cancer, recurrent breast cancer, metastatic breast cancer, er+ breast cancer, her2-positive breast cancer, palbociclib, avelumab, measurable disease, inoperable disease, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 863858
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.